9
Participants
Start Date
January 31, 2008
Primary Completion Date
August 31, 2008
Study Completion Date
AZD3480
single dose, oral
2-[18F]-F-A85380
Single dose, IV
Research Site, Stockholm
Lead Sponsor
AstraZeneca
INDUSTRY